Skip to content
10-Q

Quarterly Report

CANCER CAPITAL CORP.

0001554795-23-000131

← back to feed
Filed
May 3, 2023 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2023 · May 3, 2023 6.15M sh
Cash And Equivalents Q1 2023 · Mar 31, 2023 $17.86K
Cash And Equivalents Q1 2023 · Dec 31, 2022 $22.06K
Current Liabilities Q1 2023 · Mar 31, 2023 $440.86K
Current Liabilities Q1 2023 · Dec 31, 2022 $433.65K
Total Liabilities Q1 2023 · Mar 31, 2023 $440.86K
Total Liabilities Q1 2023 · Dec 31, 2022 $433.65K
Current Assets Q1 2023 · Mar 31, 2023 $17.86K
Current Assets Q1 2023 · Dec 31, 2022 $22.06K
Total Assets Q1 2023 · Mar 31, 2023 $17.86K
Total Assets Q1 2023 · Dec 31, 2022 $22.06K
Operating Cash Flow Q1 2023 · Mar 31, 2022 −$7.61K
Stockholders Equity Q1 2023 · Mar 31, 2022 −$383.33K
Stockholders Equity Q1 2023 · Dec 31, 2021 −$369.13K
Sga Expense Q1 2023 · Mar 31, 2022 $9.11K
Net Income Q1 2023 · Mar 31, 2022 −$14.2K
Operating Income Q1 2023 · Mar 31, 2022 −$9.11K